Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin revisited

R Rodvein, A R Cooke

    Series Haematologica (1968)
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Aspirin (ASA) effectively treats pain, fever, and arthritis with minimal gastrointestinal bleeding risk when buffered. Its anti-thrombotic effects remain uncertain, requiring physician discretion for use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Choleresis induced by stimulation of the gastric antrum.

    Journal of laparoendoscopic & advanced surgical techniques. Part A·1999
    Same author

    Images in clinical medicine. Intussusception.

    The New England journal of medicine·1997
    Same author

    Endoscopic diagnosis of whipworm.

    The American journal of gastroenterology·1994
    Same author

    Erythromycin and gastroparesis.

    Kansas medicine : the journal of the Kansas Medical Society·1990
    Same author

    Depressed natural killer cell activity in children with protein-calorie malnutrition.

    Clinical immunology and immunopathology·1982
    Same author

    Effect of tryptophan on transport properties of newborn rabbit jejunum.

    The American journal of physiology·1982
    Same journal

    Autosomal linkage in humans (methodology and results of computer analysis).

    Series haematologica (1968)·1975
    Same journal

    Platelet kinetics--1975.

    Series haematologica (1968)·1975
    Same journal

    Normal platelet numbers. Pulmonary-platelet interactions.

    Series haematologica (1968)·1975
    Same journal

    Role of platelets in hemostasis and thrombosis.

    Series haematologica (1968)·1975
    Same journal

    Static and functional morphology of the pathological platelets in primary myelofibrosis and myeloproliferative syndrome.

    Series haematologica (1968)·1975
    Same journal

    Megakaryocytes in agar cultures of mouse bone marrow.

    Series haematologica (1968)·1975
    See all related articles

    Area of Science:

    • Pharmacology
    • Gastroenterology
    • Cardiology

    Background:

    • Aspirin (ASA) is widely used for its analgesic, antipyretic, and anti-inflammatory properties.
    • Buffered and soluble formulations of ASA can mitigate its primary gastrointestinal (GI) side effect: bleeding.
    • The mechanism of ASA-induced GI bleeding is primarily attributed to local effects on the gastric mucosa.

    Purpose of the Study:

    • To evaluate the efficacy of aspirin (ASA) in managing pain, fever, and arthritis.
    • To assess the contribution of ASA's anti-platelet effects to gastrointestinal bleeding.
    • To clarify the role of ASA and other anti-platelet agents in preventing thrombosis.

    Main Methods:

    • Review of existing literature on ASA's pharmacological effects and clinical outcomes.

    Related Experiment Videos

  • Analysis of evidence regarding ASA's local gastric effects versus systemic anti-platelet activity.
  • Consideration of ongoing clinical trials investigating anti-thrombotic therapies.

    • Main Results:

    • ASA is generally safe and effective for pain, fever, and arthritis relief.
    • Evidence suggests ASA's anti-platelet effect does not significantly contribute to gastric bleeding.
    • The role of ASA in preventing thrombosis is not definitively established due to conflicting literature.

    Conclusions:

    • Buffered ASA formulations offer a safer profile by reducing GI bleeding risk.
    • Further research and clinical trials are needed to conclusively determine ASA's anti-thrombotic efficacy.
    • The decision to use ASA for anti-thrombotic purposes currently rests with individual physician judgment.